Article ID Journal Published Year Pages File Type
1070549 Drug and Alcohol Dependence 2009 9 Pages PDF
Abstract

BackgroundGenerally, urinary 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) after alkaline hydrolysis is monitored to detect cannabis exposure, although last use may have been weeks prior in chronic cannabis users. Δ9-Tetrahydrocannabinol (THC) and 11-hydroxy-THC (11-OH-THC) concentrations in urine following Escherichia coli β-glucuronidase hydrolysis were proposed as biomarkers of recent (within 8 h) cannabis use.ObjectiveTo test the validity of THC and 11-OH-THC in urine as indicators of recent cannabis use.MethodsMonitor urinary cannabinoid excretion in 33 chronic cannabis smokers who resided on a secure research unit under 24 h continuous medical surveillance. All urine specimens were collected individually ad libidum for up to 30 days, were hydrolyzed with a tandem E. coli β-glucuronidase/base procedure, and analyzed for THC, 11-OH-THC and THCCOOH by one- and two-dimensional-cryotrap gas chromatography mass spectrometry (2D-GCMS) with limits of quantification of 2.5 ng/mL.ResultsExtended excretion of THC and 11-OH-THC in chronic cannabis users’ urine was observed during monitored abstinence; 14 of 33 participants had measurable THC in specimens collected at least 24 h after abstinence initiation. Seven subjects had measurable THC in urine for 3, 3, 4, 7, 7, 12, and 24 days after cannabis cessation. 11-OH-THC and THCCOOH were detectable in urine specimens from one heavy, chronic cannabis user for at least 24 days.ConclusionFor the first time, extended urinary excretion of THC and 11-OH-THC is documented for at least 24 days, negating their effectiveness as biomarkers of recent cannabis exposure, and substantiating long terminal elimination times for urinary cannabinoids following chronic cannabis smoking.

Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Authors
, , , , , ,